Last update 08 May 2025

Janssen Ortho LLC

Subsidiary Company|Puerto Rico

Overview

Tags

Endocrinology and Metabolic Disease
Urogenital Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
SGLT2(Sodium/glucose cotransporter 2)1

Related

4
Drugs associated with Janssen Ortho LLC
Apalutamide
Target
AR
Mechanism
AR antagonists
Active Org.
Aragon Pharmaceuticals, Inc.Aragon Pharmaceuticals, Inc. [+12]
Originator Org.
Janssen Global Services LLCJanssen Global Services LLC
Active Indication
Metastatic Prostate Carcinoma [+18]
Inactive Indication
Alzheimer Disease
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United States
First Approval Date14 Feb 2018
Canagliflozin Hemihydrate
Target
SGLT2
Mechanism
SGLT2 inhibitors
Active Org.
Janssen Ortho LLC [+7]
Originator Org.
Mitsubishi Tanabe Pharma Corp.Mitsubishi Tanabe Pharma Corp.
Active Indication
Type 2 diabetes mellitus with established diabetic nephropathy [+2]
Inactive Indication
Cardiovascular Diseases [+6]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United States
First Approval Date29 Mar 2013
Ustekinumab
Target
IL-12 x IL-23
Mechanism
IL-12 inhibitors [+1]
Active Org.
Janssen Research & Development LLC [+9]
Originator Org.
Janssen Biotech, Inc.Janssen Biotech, Inc.
Active Indication
Colitis, Ulcerative [+13]
Inactive Indication
Dermatomyositis [+17]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
European Union [+3]
First Approval Date15 Jan 2009
12
Clinical Trials associated with Janssen Ortho LLC
CTR20250504
/ RecruitingPhase 4
一项关于盐酸艾司氯胺酮鼻喷雾剂在伴有急性自杀意念或行为的抑郁症（MDSI）中国患者中有效性和安全性的前瞻性、观察性、多中心研究
[Translation] A prospective, observational, multicenter study of the efficacy and safety of esketamine hydrochloride nasal spray in Chinese patients with major depressive disorder with acute suicidal ideation or behavior (MDSI)
CTR20192078
/ Active, not recruitingPhase 4
一项在非转移性去势抵抗性前列腺癌（NM-CRPC）中国受试者中进行的Apalutamide多中心、随机、双盲、安慰剂对照、IV期研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled, phase IV study of apalutamide in Chinese subjects with non-metastatic castration-resistant prostate cancer (NM-CRPC)
CTR20150744
/ CompletedPhase 3
在2型糖尿病及糖尿病肾病受试者中考察Canagliflozin对肾和心血管结局影响的随机、双盲、事件驱动、安慰剂对照、多中心研究
[Translation] A randomized, double-blind, event-driven, placebo-controlled, multicenter study to investigate the effects of Canagliflozin on renal and cardiovascular outcomes in subjects with type 2 diabetes and diabetic nephropathy
100 Clinical Results associated with Janssen Ortho LLC
Login to view more data
0 Patents (Medical) associated with Janssen Ortho LLC
Login to view more data
100 Deals associated with Janssen Ortho LLC
Login to view more data
100 Translational Medicine associated with Janssen Ortho LLC
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 16 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
1
3
Other
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free